As the president and CEO of Vir Biotechnology, as well as in his role as head of BIO’s Coronavirus Collaboration Initiative, George Scangos has emerged as a global leader in the fight against COVID-19. In this conversation with Stanford structural biology professor Jody Puglisi, Dr. Scangos explains the challenge of building financially viable therapies for infectious diseases, talks about the current status of COVID-related research, and explores how to build an innovative and meaningful career in biotech.
Related
Lynda Kate Smith,
mParticle
Marketing for Entrepreneurs [Entire Talk]
Even the greatest technology doesn’t sell itself.
Lynda Kate Smith,
mParticle
Marketing for Entrepreneurs [Entire Talk]
Even the greatest technology doesn’t sell itself.
Justin Kan,
Twitch
Finding Fulfillment in Entrepreneurship [Entire Talk]
To find satisfaction in entrepreneurship, seek joy in the process as much as the outcome.
Justin Kan,
Twitch
Finding Fulfillment in Entrepreneurship [Entire Talk]
To find satisfaction in entrepreneurship, seek joy in the process as much as the outcome.
Ashley Flucas,
Flucas Ventures
The New Angel Investing [Entire Talk]
New users are flocking to angel investing platforms. What does this mean for investors and startups?
Ashley Flucas,
Flucas Ventures
The New Angel Investing [Entire Talk]
New users are flocking to angel investing platforms. What does this mean for investors and startups?
